The link between being overweight and cancer - How redundant weight increases threat "being overweight and Cancer the Growing Epidemic" being overweight has come a global health extremity, with rates continuing to rise in both developed and developing countries.
Along with its well- known links to diabetes, heart complaint, and other habitual conditions, exploration has also shown a strong association between being overweight and cancer. In this post, we will explore the mechanisms by which redundant weight increases cancer threat and the way individualities can take to reduce that threat.
Being overweight is defined as having a body mass indicator(BMI) of 30 or advanced. This redundant weight can lead to habitual inflammation throughout the body, which in turn can lead to the development of cancer. Studies have shown that the threat of certain types of cancer, similar as bone, colon, endometrial, and order cancer, is significantly advanced in fat individualities.
The threat is indeed lesser for those who are morbidly fat, with a BMI of 40 or advanced. One of the crucial ways in which being overweight increases cancer threat is through the product of hormones similar as estrogenic and insulin. In fat individualities, there's an overproduction of these hormones, which can fuel the growth of cancer cells. also, fat cells produce a protein called leptin, which can also promote the growth of cancer cells. Another way that being overweight increases cancer threat is through the accumulation of fat in the liver.
This can lead to the development of Non-alcoholic adipose liver complaint (NAFLD), which is a threat factor for liver cancer still, it's important to note that not all cancer is linked to rotundity. Some cancer similar as lung cancer, prostate cancer, etc has other main causes similar as smoking, exposure to poisons, etc.
The good news is that there are way individualities can take to reduce their threat of developing cancer, indeed if they're formerly fat.
These include:
Read more such content on Hidoc Dr | Medical Learning App for Doctors
1.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
2.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
3.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
4.
Month-Long Wait Times Caused by US Physician Shortage.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
3.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
4.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation